Revvity Inc (NYSE:RVTY)
$ 116.14 -0.09 (-0.08%) Market Cap: 14.13 Bil Enterprise Value: 16.22 Bil PE Ratio: 56.19 PB Ratio: 1.79 GF Score: 81/100

PerkinElmer Inc at Robert W Baird Global Healthcare Conference Transcript

Sep 13, 2022 / 02:50PM GMT
Release Date Price: $132.71 (-6.79%)
Thomas Peterson
Robert W. Baird & Co. Incorporated, Research Division - Research Analyst

Thanks, everyone. Welcome. Thank you for joining. I'm Tom Peterson, I'm an associate here on our Life Sciences and Tools list here at Baird. We're excited to have PerkinElmer presenting today. And representing the company, we have CEO, Prahlad Singh. Prahlad, welcome.

Prahlad R. Singh
PerkinElmer, Inc. - CEO, President & Director

Thank you, Tom.

Thomas Peterson
Robert W. Baird & Co. Incorporated, Research Division - Research Analyst

So as far as the agenda, I think Prahlad, you're going to give an overview here with a couple of slides, and then we'll hop into Q&A.

Prahlad R. Singh
PerkinElmer, Inc. - CEO, President & Director

Yes. I mean rather than those slides, I'll -- I'm much more comfortable just talking. So here it goes. We are really at an exciting stage in the life cycle of our company. Our recent announcement of the divestment of the Applied and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot